Top-News
  • Watchlist
  • Glocke
  • Handeln

    • CAC 40 Index News

    8.088,85 -0,21% -16,715
    19:07:20 Uhr Ariva Indikation aktualisieren | Orderbuch | Mehr Kurse »
    WKN: 969400
    ISIN: FR0003500008
    Typ: Index
    Werbung
    Weiter abwärts?
    Short Hebel 14,80
    MB3S59

    Ad-hocs

    08:26 Uhr - LYNX Analysen
    Kering: Ein Wort könnte die Aktie heute wieder ins Trudeln bringen
    Dass der Umsatz des französischen Mode- und Luxusgüterkonzerns Kering (u.a. Gucci) im ersten Quartal sinken würde, wusste man längst. Doch die Aussage, die der Chef des ...  Mehr »
    15.04.24 - Société Générale
    Airbus – Korrektur im Aufwärtstrend
    Die Aktie der  Airbus Group (WKN: 938914) bewegt sich ausgehend vom Corona-​Crash-Tief aus dem Jahr 2020 bei 47,70 EUR in einem  intakten langfristigen Aufwärtstrend . Im ...  Mehr »
    23.04.24 - GlobeNewswire
    ArcelorMittal S.A.: ArcelorMittal publishes its 2023 Integrated Annual Review
    23 April 2024, 15:00 CET
    23.04.24 - GlobeNewswire
    Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
    Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
    18.04.24 - GlobeNewswire
    First quarter 2024 sales
    A very good start to the year
    17.04.24 - GlobeNewswire
    Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis
    New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis
    10.04.24 - GlobeNewswire
    ArcelorMittal S.A.: ArcelorMittal publishes interim update on its company-wide safety audit
    10 April 2024, 16:45 CET
    29.03.24 - GlobeNewswire
    ArcelorMittal publishes convening notice for its Annual General Meeting of shareholders
    29 March 2024, 08:00 CET
    27.03.24 - GlobeNewswire
    ArcelorMittal announces publication of the 2023 statutory financial statements of ArcelorMittal parent company
    27 March 2024, 20:15 CET
    27.03.24 - GlobeNewswire
    ArcelorMittal publishes revised analyst model per new segmental reporting
    27 March 2024, 10:30 CET
    22.03.24 - GlobeNewswire
    Press Release: Availability of the Q1 2024 Memorandum for modelling purposes
    Availability of the Q1 2024 Memorandum for modelling purposes
    19.03.24 - GlobeNewswire
    Annual General Meeting to be held on Tuesday 23 April 2024 and 2023 Universal Registration Document
    L’Oréal, the world’s leading beauty company, announced terms of information availability regarding the Annual General Meeting to be held on Tuesday 23 April 2024 and the 2023 ...
    19.03.24 - GlobeNewswire
    ArcelorMittal S.A.: ArcelorMittal announces Kleber Silva to be new CEO of ArcelorMittal Mining
    19 March 2024, 10:00 CET
    12.03.24 - GlobeNewswire
    ArcelorMittal S.A.: ArcelorMittal acquires strategic stake in Vallourec
    12 March 2024, 22:00 CET
    11.03.24 - GlobeNewswire
    Press Release: New Phase 2b results for amlitelimab support potential for best-in-class maintenance of response in atopic dermatitis
    New Phase 2b results for amlitelimab support potential for best-​in-class maintenance of response in atopic dermatitis
    28.02.24 - GlobeNewswire
    ArcelorMittal S.A.: ArcelorMittal announces the publication of its 2023 annual report
    28 February 2024, 21:40 CET
    28.02.24 - GlobeNewswire
    ArcelorMittal S.A.: ArcelorMittal publishes its Annual Report 2023 on Form 20-F
    28 February 2024, 20:55 CET
    24.02.24 - GlobeNewswire
    Press Release: Phase 2 results demonstrate rilzabrutinib rapidly reduced itch severity and significantly improved disease activity in adults with chronic spontaneous urticaria
    Phase 2 results demonstrate rilzabrutinib rapidly reduced itch severity and significantly improved disease activity in adults with chronic spontaneous urticaria
    23.02.24 - GlobeNewswire
    Press Release: Filing of the 2023 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
    Filing of the 2023 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
    23.02.24 - GlobeNewswire
    Press Release: Dupixent® sBLA accepted for FDA Priority Review for treatment of COPD with type 2 inflammation
    Dupixent ® sBLA accepted for FDA Priority Review for treatment of COPD with type 2 inflammation
    22.02.24 - GlobeNewswire
    Capgemini to acquire Unity’s Digital Twin Professional Services arm to accelerate enterprises’ digital transformation through real-time 3D technology
    Capgemini press contact: Sam Connatty Tel: +44 370 904 3601
    22.02.24 - GlobeNewswire
    Press Release: Sanofi’s Board of Directors proposes the appointment of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy as independent Directors
    Sanofi’s Board of Directors proposes the appointment of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy as independent Directors

    Newssuche

    Videos

    08:50 Uhr 0,00%
    Technical Trading: AUD/USD mit Mega Chance
    AUD/USD Long Typ: Turbo Open End WKN: UM0EHU Hebel: 6,42 Laufzeit: OpenEnd Einstieg: Market ... Mehr »